Amylin stoops to new low

Discussion in 'Amylin' started by Anonymous, Jun 29, 2012 at 1:24 AM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    VMS Biomarketing has employed CDE's to switch patients to Bydureon for $250 a patient. This will be coming to an end soon trust me. Hope you aren't one of the reps looking at patient charts to help with switches. Big trouble coming for the Baton Rouge Rep.
     

  2. Anonymous

    Anonymous Guest

    I already know this is a load of crap otherwise I would be advertising it.
     
  3. Anonymous

    Anonymous Guest

    I don't put anything past the shady COONASSES in LA. That entire state needs to have a fence around it so all the swamp people can't infect the others.
     
  4. Anonymous

    Anonymous Guest

    Agree